《大行》匯豐研究:浙江滬杭甬(00576.HK)雙重上市料增加派息 維持買入目標價7.7元
匯豐環球研究報告指,浙江滬杭甬(00576.HK)建議以發行A股方式換股吸收合併鎮洋發展(603213.SH),實現「A+H」兩地上市,而目前由母公司國企所持有的非流通股份亦將於A股市場上市流通。計劃有待相關部分批准,預計需時12至18個月完成。
該行認為,此舉將為未來道路擴建或併購提供資金,吸引國內投資者,並縮窄與其他兩地上市同業的估值差距;維持「買入」評級及目標價7.7元不變,因集團表示雙重上市後3年,每股股息將不少於0.41元人民幣,相較於去年為0.385元人民幣,意味收益率達6%,具吸引力,且集團證券業務有潛在增長空間。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.